These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23941737)

  • 21. TAVI registries: full disclosure?
    Ennezat PV; Le Jemtel TH
    Arch Cardiovasc Dis; 2013; 106(6-7):417-8. PubMed ID: 23876812
    [No Abstract]   [Full Text] [Related]  

  • 22. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?
    Watanabe Y; Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    Catheter Cardiovasc Interv; 2013 May; 81(6):1053-60. PubMed ID: 23074135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European experience and perspectives on transcatheter aortic valve replacement.
    Davies WR; Thomas MR
    Prog Cardiovasc Dis; 2014; 56(6):625-34. PubMed ID: 24838138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
    Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation.
    Nuis RJ; Rodés-Cabau J; Sinning JM; van Garsse L; Kefer J; Bosmans J; Dager AE; van Mieghem N; Urena M; Nickenig G; Werner N; Maessen J; Astarci P; Perez S; Benitez LM; Dumont E; van Domburg RT; de Jaegere PP
    Circ Cardiovasc Interv; 2012 Oct; 5(5):680-8. PubMed ID: 23048055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in patients undergoing TAVI: a multicentre study.
    D'Ascenzo F; Gonella A; Moretti C; Omedè P; Salizzoni S; La Torre M; Giordana F; Barbanti M; Ussia GP; Brambilla N; Bedogni F; Gaita F; Tamburino C; Sheiban I
    EuroIntervention; 2013 Jul; 9(3):367-72. PubMed ID: 23872650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of cerebral injury following transfemoral aortic valve implantation.
    Ghanem A; Müller A; Sinning JM; Kocurek J; Becker BV; Vogel M; Vasa-Nicotera M; Hammerstingl C; Schwab JO; Nähle CP; Thomas D; Wagner M; Grube E; Werner N; Nickenig G
    EuroIntervention; 2013 Mar; 8(11):1296-306. PubMed ID: 23538093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
    Kappetein AP; Head SJ; Généreux P; Piazza N; van Mieghem NM; Blackstone EH; Brott TG; Cohen DJ; Cutlip DE; van Es GA; Hahn RT; Kirtane AJ; Krucoff MW; Kodali S; Mack MJ; Mehran R; Rodés-Cabau J; Vranckx P; Webb JG; Windecker S; Serruys PW; Leon MB
    Eur Heart J; 2012 Oct; 33(19):2403-18. PubMed ID: 23026477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transcatheter aortic valve implantation in patients with severe aortic stenosis].
    Bjerre Thygesen J; Loh PH; Franzen O; Søndergaard L
    Ugeskr Laeger; 2012 Oct; 174(43):2620-4. PubMed ID: 23095650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JenaValve.
    Treede H; Rastan A; Ferrari M; Ensminger S; Figulla HR; Mohr FW
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q88-93. PubMed ID: 22995119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single center experience with transcatheter aortic valve implantation using the Edwards SAPIEN™ Valve.
    Nielsen HH; Thuesen L; Egeblad H; Poulsen SH; Klaaborg KE; Jakobsen CJ; Andersen HR; Hjortdal VE
    Scand Cardiovasc J; 2011 Oct; 45(5):261-6. PubMed ID: 21506661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
    J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis.
    Ussia GP; Barbanti M; Cammalleri V; Scarabelli M; Mulè M; Aruta P; Pistritto AM; Immè S; Capodanno D; Sarkar K; Gulino S; Tamburino C
    EuroIntervention; 2011 Sep; 7(5):573-9. PubMed ID: 21930461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
    Bosmans JM; Kefer J; De Bruyne B; Herijgers P; Dubois C; Legrand V; Verheye S; Rodrigus I;
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):762-7. PubMed ID: 21349890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.
    Dahle G; Rein KA; Fiane A; Fosse E; Khushi I; Hagen T; Mishra V
    Scand Cardiovasc J; 2012 Dec; 46(6):345-52. PubMed ID: 22917262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The benefits from TAVI: mortality and beyond.
    Carroll JD
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1127-8. PubMed ID: 20517976
    [No Abstract]   [Full Text] [Related]  

  • 39. How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation?
    Saia F; Marrozzini C; Dall'Ara G; Russo V; Martìn-Suàrez S; Savini C; Ortolani P; Palmerini T; Taglieri N; Bordoni B; Pilato E; Di Bartolomeo R; Branzi A; Marzocchi A
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):727-32. PubMed ID: 20414120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation.
    Hayashida K; Lefèvre T
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q34-40. PubMed ID: 22995110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.